DFT Calculations, Molecular Docking, and Pharmacological Properties Investigation for 5-Benzoxazolecarboxylic Acid as a Target Anti-Cancer Agent

Yıl 2024, Cilt: 28 Sayı: 2, 314 - 325, 30.04.2024

Ceyhun Küçük

https://doi.org/10.16984/saufenbilder.1333717

Öz

In this study, the electronic properties of the 5-Benzoxazolecarboxylic acid molecule, a benzoxazole derivative, were calculated at the DFT/B3LYP/6-311++G(d,p) level of theory. Electronic properties and chemical reactivity of the optimized structure, such as Frontier molecular orbital (FMO), global and chemical reactivity descriptors, molecular electrostatic potential (MEP), and charge analyses (APT, Hirshfeld, and NBO), were investigated. Also, electronic properties are supported by electron localization function (ELF) and localized orbital locator (LOL) analyses. Toxicity effects such as mutagenic, tumorigenic, irritant, reproductive effect, and physicochemical properties such as druglikeness and drugscore were investigated. Molecular docking studies were conducted with the vascular endothelial growth factor receptor VEGFR-2 and the PARP-2 inhibitor, which is involved in many critical cellular processes, including DNA single-stranded fracture repair and cell death control, and its effectiveness in cancer treatment was investigated.

Anahtar Kelimeler

5-benzoxazolecarboxylic Acid, DFT, Toxicity, ELF, Molecular Docking

Kaynakça

• [1] Kamal, K. S. Reddy, M. Naseer, M. J. Ramaiah, “Synthesis, DNA binding ability and anticancer activity of benzthiazole/benzoxazolepyrrolo[2,1-c][1,4]benzodiazepine conjugates,’’ Bioorganic & Medicinal Chemistry Letters, vol.18, pp. 4747-4761, 2010.
• [2] H. Lage, E. Aki-Sener, I. Yalcin, “High antineoplastic activity of new heterocyclic compounds in cancer cells with resistance against classical DNA topoisomerase II-targeting drugs,’’ International Journal of Cancer, vol. 119, no.1, pp. 213-220, 2006.
• [3] M. Arisoy, O. T. Arpaci, F. K. Onurdag, S. Ozgen, “Synthesis and antimicrobial activity of novel benzoxazoles,’’ Zeitschrift für Naturforschung C, vol. 67, no. 9-10, pp. 466-472, 2012.
• [4] L. Srikanth, R. Jadha, K. Manohar, “Synthesis and evaluation of new phenylamino-thiadiazolo-oxadiazolo-1,3-benzoxazoles for their antifungal and anti-inflammatory activity,’’ Der Pharma Chemica, vol. 2, pp.231-243, 2010.
• [5] D. N. Ward, D. C. Talley, M. Tavag, S. Menji, P. Schaughency, A. Baier, P. J. Smith, “UK-1 and structural analogs are potent inhibitors of hepatitis C virus replication,’’ Bioorganic & Medicinal Chemistry Letters, vol. 24, no. 2, pp. 609-612, 2014.
• [6] A. Srinivas, J. Vidyasagar, M. Sarangapani, “Design, synthesis and biological evaluation of benzoxazole derivatives as new antiinflammatory agents,’’ Journal of Chemical and Pharmaceutical Research, vol. 2 pp. 319-326, 2010.
• [7] M. Sham, S. N. Singh, A. Kumar, L. Meijer, “Synthesis, antiinflammatory, analgesic and kinase (CDK-1, CDK-5 and GSK-3) inhibition activity evaluation of benzimidazole/benzoxazole derivatives and some schiff’s bases,’’ Bioorganic & Medicinal Chemistry Letters vol. 14, pp. 3758-3765, 2006.
• [8] Celik, M. Erol, O. T. Arpaci, F. S. Senol, I. E. Orhan, “Evaluation of activity of some 2,5-disubstituted benzoxazole derivatives against acetylcholinesterase, butyrylcholinesterase and tyrosinase: ADME prediction, DFT and comparative molecular docking studies,’’ Polycyclic Aromatic Compounds, vol. 42, no. 2, pp. 412–423, 2020.
• [9] S. M. Rida, F. A. Ashour, A. M. Soad, E. Hawash, M. Mona, H. B. Mona. “Synthesis of some novel benzoxazole derivatives as anticancer, antiHIV1 and antimicrobial agents,’’ European Journal of Medicinal Chemistry vol. 40, pp. 949-959, 2005.
• [10] T. Zeyrek, B. Boyacioglu, Ö. T. Arpaci, H. Ünver, A. Elmali, “Spectroscopic, quantum mechanical and molecular docking studies of a new benzoxazole compound with an oxidoreductase enzyme and DNA,’’ Journal of Molecular Structure, vol. 1136, pp. 112-126, 2017.
• [11] P. Anand, A. B. Kunnumakkara, C. Sundaram, K. B. Harikumar, S. T. Tharakan, O. S. Lai, B. Sung, B. B. Aggarwal, “Cancer is preventable disease that requires major lifestyle changes,’’ Pharmaceutical Research, vol. 25, pp. 2097-2116, 2008.
• [12] H. Lage, E. A. Sener, I. Yalcin, “High anti-neoplastic activity of new heterocyclic compounds in cancer cells with resistance against classical DNA topoisomerase-II targeting drugs,’’ International Journal of Cancer, vol. 119, no. 1, pp. 213-220, 2006.
• [13] S. Vijayan, D. S. Janardhanam, M. Karthikeyan, J. Sunitha, R. J. Raghunatham, “Laison between microorganisms and oral cancer,’’ Journal of Pharmacy & Bioallied Sciences, vol. 7, pp. 354-360, 2015.
• [14] S. Grivennikov, F. R. Greten, M. Karin, “Immunity, Inflammation, and Cancer,’’ Cell, vol. 140 no. 6, pp. 883-899, 2010.
• [15] Kuzu, C. Hepokur, M. A. Alagoz, S. Burmaoglu, O. Algul, “Synthesis, Biological Evaluation and In Silico Studies of Some 2-Substituted Benzoxazole Derivatives as Potential Anticancer Agents to Breast Cancer,’’ ChemsitrySelect, vol. 7, no. 1, pp. e202103559, 2022.
• [16] S. Desai, V. Desai, S. Shingade, “In-vitro Anti-cancer assay and apoptotic cell pathway of newly synthesized benzoxazole-N-heterocyclic hybrids as potent tyrosine kinase inhibitors,’’, Bioorganic Chemistry, vol. 94, pp.103382, 2020.
• [17] B. Ravinaik, D. Ramachandran, M. V. B. Rao, “Synthesis and Anticancer evaluation of Amide Derivatives of 1,3,4 –oxadiazole linked with Benzoxazole,’’ Russian Journal of General Chemistry vol. 89, no. 5, pp. 1003–1008, 2019.
• [18] S. Pervaram, D. Ashok, M. Sarasija, C. V. R. Reddy, G. Sridhar, “Synthesis and Anticancer Activity of 1,2,4-Oxadiazole Fused Benzofuran Derivatives,’’ Russian Journal of General Chemistry, vol. 88, pp. 1219-1223, 2018.
• [19] Fan, A. Fu, L. Zhang, “Progress in molecular docking,’’ Quantitative Biology, vol. 7 pp. 83-89, 2019.
• [20] M. A. Abdelgawad, A. Belal, H. A. Omar, L. Hegazy, M. E. Rateb, “Synthesis, Anti-Breast Cancer Activity, and Molecular Modeling of Some Benzothiazole and Benzoxazole Derivatives,’’ Arch Pharm Chemistry in Life Sciences, vol. 346, no. 7, pp. 534-541, 2013.
• [21] A. G. A. El-Helby, H. Sakr, İ. H. İsa, A. A. Al-Karmalawy, K. El-Adl, “Benzoxazole / benzothiazole-derived VEGFR - 2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations,’’ Archiv der Pharmazie-Chemistry in Life Sciences, vol. 352, no. 12, pp. 1900178, 2019.
• [22] Y. Shao, L. F. Molnar, Y. Jung, J. Kussmann, C. Ochsenfeld, S. T. Brown, A. T. B. Gilbert, L. V. Slipchenko, S. V. Levchenko, D. P. O’Neill, R. A. DiStasio Jr, R. C. Lochan, T. Wang, G. J. O. Beran, N. A. Besley, J. M. Herbert, C. Y. Lin, T.V. Voorhis, S. H. Chien, A. Sodt, R. P. Steele, V. A. Rassolov, P. E. Maslen, P. P. Korambath, R. D. Adamson, B. Austin, J. Baker, E. F. C. Byrd, H. Dachsel, R. J. Doerksen, A. Dreuw, B. D. Dunietz, A. D. Dutoi, T. R. Furlani, S. R. Gwaltney, A. Heyden, S. Hirata, C. P. Hsu, G. Kedziora, R. Z. Khalliulin, P. Klunzinger, A. M. Lee, M. S. Lee, W. Liang, I. Lotan, N. Nair, B. Peters, E. I. Proynov, P. A. Pieniazek, Y. M. Rhee, J. Ritchie, E. Rosta, C. D. Sherrill, A. C. Simmonett, J. E. Subotnik, H. L. Woodcock III, W. Zhang, A. T. Bell, A. K. Chakraborty, D. M. Chipman, F. J. Keil, A. Warshel, W. J. Hehre, H. F. Schaefer III, J. Kong, A. I. Krylov, P. M. W Gill, M. H. Gordon, “Advances in methods and algorithms in a modern quantum chemistry program package,’’ Physical Chemistry Chemical Physics, vol. 8, pp. 3172-3191, 2016.
• [23] S. Çelik, “Conformational Analysis and DFT Investigations of 1-(4-Fluorophenyl) Piperazine by ELF and LOL, Inhibitory Activity Against Alzheimer’s Disease, and ADME Prediction,’’ Sakarya Üniversitesi Fen Bilimleri Enstitüsü Dergisi, vol. 26, no. 5, pp. 931-941, 2022.
• [24] M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng, J. L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J. A. Montgomery, Jr., J. E. Peralta, F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. N. Kudin, V. N. Staroverov, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyengar, J. Tomasi, M. Cossi, N. Rega, J. M. Millam, M. Klene, J. E. Knox, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin, K. Morokuma, V.G. Zakrzewski, G. A. Voth, P. Salvador, J. J. Dannenberg, S. Dapprich, A. D. Daniels, O. Farkas, J. B. Foresman, J. V. Ortiz, J. Cioslowski, D. J. Fox., “Gaussian Inc,’’ Wallingford CT, 2009.
• [25] R. Dennington, T. Keith, J. Millam, “GaussView Version 5,’’ Semichem Inc., Shawnee Mission KS., 2009.
• [26] B. Silvi, A. Savin, “Classification of chemical bonds based on topological analysis of electron localization functions,’’ Nature, 371, pp. 683-686, 1994.
• [27] Dassault Systemes BIOVIA, Discovery Studio Visualizer v17.2.0.16349, 2016. San Diego
• [28] Organic Chemistry Portal OSIRIS Property Explorer , (2023, Jul. 20.) Available: http://www.organic-chemistry.org/prog/peo/
• [29] Kucuk, S. Yurdakul, B. Erdem. “Combined Experimental and Theoretical Spectroscopic Properties (FT-IR, FT-Ra, Uv-Vis, and NMR), DFT Studies, Biological Activity, Molecular Docking, and Toxicity Investigations of 3-methoxy-1-piperazinylbenzene,’’ Letters in Organic Chemistry, vol. 20, no. 5, pp. 457-480, 2023.
• [30] M. N. Ahmed, K. A. Yasin, K. Ayub, T. Mahmood, M. N. Tahir, B. A. Khan, M. Hafeez, M. Ahmed, I. ul-Haq, “Click one pot synthesis, spectral analyses, crystal structures, DFT studies and brine shrimp cytotoxicity assay of two newly synthesized 1,4,5-trisubstituted 1,2,3- triazoles,’’ Journal of Molecular Structure, vol. 1106, pp. 430-439, 2016.
• [31] M. Arshad, A. Bibi, T. Mahmood, A. Asiri, K. Ayub, “Synthesis, crystal structures and spectroscopic properties of triazine-based hydrazone derivatives; a comparative experimental-theoretical study, “Molecules, vol. 20, pp. 5851-5874, 2015.
• [32] M. Evecen, “Structural, Conformational and Spectroscopic Properties of C16H16BrNO3 SchiffBase Molecule: A Theoretical Investigation,” Sakarya Üniversitesi Fen Bilimleri Enstitüsü Dergisi, vol. 22, pp. 1591-1600, 2018.
• [33] M. Noreen, N. Rasool, Y. Gull, M. Zubair, T. Mahmood, K. Ayub, F.-H. Nasim, A. Yaqoob, M. Zia-Ul-Haq, V. Feo, “Synthesis, density functional theory (DFT), urease inhibition and antimicrobial activities of 5-aryl thiophenes bearing sulphonylacetamide moieties,’’ Molecules, vol. 20, pp. 19914-19928, 2015.
• [34] S. D. Oladipo, G. F. Tolufashe, C. Mocktar, B. Omondi, “Ag(I) symmetrical N,N′ -diarylformamidine dithiocarbamate PPh3 complexes: Synthesis, structural characterization, quantum chemical calculations and in vitro biological studies,” Inorganica Chimica Acta, vol. 520, pp. 120316, 2021.
• [35] S. J. Basha, S. P. V. Chamundeeswari, S. Muthu, B. R. Raajaraman, “Quantum computational, spectroscopic investigations on 6- aminobenzimidazole by DFT/TD-DFT with different solvents and molecular docking studies,’’ Journal of Molecular Liquids, vol. 296, pp. 11178, 2019.
• [36] T. Chaudharya, M. K. Chaudharya, B. D. Joshi, M. S. A. de Santana, A. P. Ayala, “Spectroscopic (FT-IR, Raman) analysis and computational study on conformational geometry, AIM and biological activity of cephalexin from DFT and molecular docking approach,’’ Journal of Molecular Structure, vol. 1240, pp. 130594, 2021.
• [37] H. P. Gümüş, Ö. Tamer, Y. Atalay, “4- (Metoksimetil)-1,6-dimetil-2-okso-1,2- dihidropiridin-3-karbonitril molekülünün teorik olarak incelenmesi,” Sakarya Üniversitesi Fen Bilimleri Enstitüsü Dergisi, vol. 19 no 3, pp. 303 -311, 2015.
• [38] N. Okulik, A. H. Jubert “Theoretical study on the structure and reactive sites of nonsteroidal anti-inflammatory drugs,” Journal of Molecular Structure: THEOCHEM, vol. 682, pp. 55-62, 2004.
• [39] B. Şaş, S. Çiftçi, M. KURT, “Spectroscopic Characterization and DFT Calculations on 1H-benzimidazole-2-carboxylic acid monohydrate Molecule,” Sakarya Üniversitesi Fen Bilimleri Enstitüsü Dergisi, vol. 26, no. 5, pp. 879-891, 2022.
• [40] B. F. Rizwana, J. C. Prasana, S. Muthu, C. S. Abrahama, “Molecular docking studies, charge transfer excitation and wave function analyses (ESP, ELF, LOL) on valacyclovir: a potential antiviral drug,’’ Computational Biological Chemistry, vol. 78, pp. 9 -17, 2019.
• [41] A. Atilgan, Ş. Yurdakul, Y. Erdoğdu, M. T. Güllüoğlu, “DFT simulation, quantum chemical electronic structure, spectroscopic and structure-activity investigations of 4-acetylpyridine,” Journal of Molecular Structure, vol. 1161, pp. 55-65, 2018.
• [42] Uetrecht, “Prediction of a new drug's potential to cause idiosyncratic reactions,” Current Opinion in Drug Discovery and Development, vol. 4, no. 1, pp. 55-59, 2001.
• [43] M Ishikawa, Y. J. Hashimoto, “Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry,” Journal of medicinal Cemistry, vol. 54, no. 6, pp. 1539-1554, 2011.
• [44] T. P. Begley, “Wiley Encyclopedia of Chemical Biology, Volume 1,” Wiley, New York, 2009.
• [45] Di, E. H. Kerns, “Blood-Brain Barrier in Drug Discovery: Optimizing Brain Exposure of CNS Drugs and Minimizing Brain Side Effects for Peripheral Drugs,” John Wiley & Sons, 2015.
• [46] M.A. de Brito, “Pharmacokinetic study with computational tools in the medicinal chemistry course,” Brazilian Journal of Pharmaceutical Sciences, vol. 47, no. 4, pp. 797-805, 2011.
• [47] Guan, H. Yang, Y. Cai L. Sun, P. Di, W. Li, Y. Tang, “ADMET-score – a comprehensive scoring function for evaluation of chemical drug-likeness,” Medicinal Chemistry Communication, vol. 10, no. 1, pp. 148-157, 2019.
• [48] RCSB PDB Protein Data Bank, (2023, Jul. 20.) Available:https://www.rcsb.org/
• [49] K. Haruna, V. S. Kumar, Y. S. Maray, S. A. Popoola, R. Thomas, M. S. Roxy, A. A. Al-Saadi, “Conformational profile, vibrational assignments, NLO properties and molecular docking of biologically active herbicide1,1-dimethyl-3-phenylurea,” Heliyon, vol. 5, pp. e01987, 2019.
• [50] J. L. Stigliani, V. B. Genisson, J. Bernadou, G. Pratviel, “Cross-docking study on InhA inhibitors: a combination of Autodock Vina and PM6-DH2 simulations to retrieve bio-active conformations,” Organic & Biomolecular Chemistry, vol. 10, pp. 6341–6349, 2012.